Low prevalence of HPV detection and genotyping in non-muscle invasive bladder cancer using single-step PCR followed by reverse line blot

Cobos C, Figueroa JA, Mirandola L, Colombo M, Summers G, Figueroa A, Aulakh A, Konala V, Verma R, Riaz J, Wade R, Saadeh C, Rahman RL, Pandey A, Radhi S, Nguyen DD, Jenkins M, Chiriva-Internati M, Cobos E (2014) The role of human papilloma virus (HPV) infection in non-anogenital cancer and the promise of immunotherapy: a review. Int Rev Immunol 33(5):383–401 Tolstov Y, Hadaschik B, Pahernik S, Hohenfellner M, Duensing S (2014) Human papillomaviruses in urological malignancies: a critical assessment. Urol Oncol 32(1):46.e19–46.e27 Youshya S, Purdie K, Breuer J, Proby C, Sheaf MT, Oliver RT, Baithun S (2005) Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis. J Clin Pathol 58(2):207–210 Alexander RE, Hu Y, Kum JB, Montironi R, Lopez-Beltran A, Maclennan GT, Idrees MT, Emerson RE, Ulbright TM, Grignon DG, Eble JN, Cheng L (2012) p16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma. Mod Pathol 25(11):1526–1533 Li N, Yang L, Zhang Y, Zhao P, Zheng T, Dai M (2011) Human papillomavirus infection and bladder cancer risk: a meta-analysis. J Infect Dis 204(2):217–223 Kim SH, Joung JY, Chung J, Park WS, Lee KH, Seo HK (2014) Detection of human papillomavirus infection and p16 immunohistochemistry expression in bladder cancer with squamous differentiation. PLoS One 9(3):e93525 Khaled HM, Bahnassi AA, Zekri AR, Kassem HA, Mokhtar N (2003) Correlation between p53 mutations and HPV in bilharzial bladder cancer. Urol Oncol 21(5):334–341 Ward C, Pedraza J, Kavanagh K, Johannessen I, Cuschieri K (2014) An evaluation of the Qiagen HPV sign for the detection and genotyping of cervical lesions and oropharyngeal squamous cell carcinomas. J Virol Methods 207C:128–132 Hubbard RA (2003) Human papillomavirus testing methods. Arch Pathol Lab Med 127(8):940–945 Lungu O, Wright TC, Silverstein S (1992) Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis. Mol Cell Probes 6:145–152 Laconi S, Greco M, Pellegrini-Bettoli P, Rais M, Laconi E, Pani P (2001) One-step detection and genotyping of human papillomavirus in cervical samples by reverse hybridization. Diagn Mol Pathol 10:200–206 Mills A, Balasubramaniam R, Longacre TA, Kong CS, Pinsky BA (2013) Laboratory-developed L1 sequencing and type-specific, real-time polymerase chain reaction for the detection and typing of human papillomaviruses in formalin-fixed, paraffin-embedded tissues. Arch Pathol Lab Med 137(1):50–54 Steenbergen RD, Snijders PJ, Heideman DA, Meijer CJ (2014) Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions. Nat Rev Cancer 14(6):395–405 Conesa-Zamora P, Doménech-Peris A, Orantes-Casado FJ, Ortiz-Reina S, Sahuquillo-Frías L, Acosta-Ortega J, García-Solano J, Pérez-Guillermo M (2009) Effect of human papillomavirus on cell cycle-related proteins p16, Ki-67, Cyclin D1, p53, and ProEx C in precursor lesions of cervical carcinoma: a tissue microarray study. Am J Clin Pathol 132(3):378–390 Gould VE, Schmitt M, Vinokurova S, Reddy VB, Bitterman P, Alonso A, Gattuso P (2010) Human papillomavirus and p16 expression in inverted papillomas of the urinary bladder. Cancer Lett 292(2):171–175 Piaton E, Casalegno JS, Advenier AS, Decaussin-Petrucci M, Mege-Lechevallier F, Ruffion A, Mekki Y (2014) p16INK4a overexpression is not linked to oncogenic human papillomaviruses in patients with high-grade urothelial cancer cells. Cancer Cytopathol 122(3):211–220. doi:10.1002/cncy.21376 Steinestel J, Cronauer MV, Müller J, Al Ghazal A, Skowronek P, Arndt A, Kraft K, Schrader M, Schrader AJ, Steinestel K (2013) Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infection. PLoS One 8(5):e65189 Alexander RE, Williamson SR, Richey J, Lopez-Beltran A, Montironi R, Davidson DD, Idrees MT, Jones CL, Zhang S, Wang L, Rao Q, Pedrosa JA, Kaimakliotis HZ, Monn MF, Koch MO, Cheng L (2014) The expression patterns of p53 and p16 and an analysis of a possible role of HPV in primary adenocarcinoma of the urinary bladder. PLoS One 9(4):e95724 Pierik A, Zwanenburg C, Moerland E, Broer D, Stapert H, van den Brule AJ (2011) Rapid genotyping of human papillomavirus by post-PCR array-based hybridization techniques. J Clin Microbiol 49(4):1395–1402 Shigehara K, Sasagawa T, Kawaguchi S, Nakashima T, Shimamura M, Maeda Y, Konaka H, Mizokami A, Koh E, Namiki M (2011) Etiologic role of human papillomavirus infection in bladder carcinoma. Cancer 117(10):2067–2076 Brunner A, Verdorfer I, Prelog M, Mayerl C, Mikuz G, Tzankov A (2008) Large-scale analysis of cell cycle regulators in urothelial bladder cancer identifies p16 and p27 as potentially useful prognostic markers. Pathobiology 75(1):25–33 Spruck CH 3rd, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, Lerner SP, Schmütte C, Yang AS, Cote R et al (1994) Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 54(3):784–788 Lopez-Beltran A, Escudero AL, Vicioso L, Muñoz E, Carrasco JC (1996) Human papillomavirus DNA as a factor determining the survival of bladder cancer patients. Br J Cancer 73(1):124–127 López-Beltrán A, Escudero AL, Carrasco-Aznar JC, Vicioso-Recio L (1996) Human papillomavirus infection and transitional cell carcinoma of the bladder. Immunohistochemistry and in situ hybridization. Pathol Res Pract 192(2):154–159 Heidegger I, Pichler R, Müller B, Klocker H, Oswald D, Haid B, Zelger B, Horninger W, Oswald J (2013) Is real-time PCR the correct method to evaluate the incidence of human papillomavirus in prepuces of asymptomatic boys and men? World J Urol 32(5):1199–1204. doi:10.1007/s00345-013-1190-4 Klinglmair G, Pichler R, Zelger B, Dogan HS, Becker T, Esterbauer J, Riccabona M, Loidl W, Horninger W, Oswald J (2013) Prevalence of the human papillomavirus (HPV) expression of the inner prepuce in asymptomatic boys and men. World J Urol 31(6):1389–1394 Biedermann K, Dandachi N, Trattner M, Vogl G, Doppelmayr H, Moré E, Staudach A, Dietze O, Hauser-Kronberger C (2004) Comparison of real-time PCR signal-amplified in situ hybridization and conventional PCR for detection and quantification of human papillomavirus in archival cervical cancer tissue. J Clin Microbiol 42(8):3758–3765 Karlsen F, Kalantari M, Chitemerere M, Johansson B, Hagmar B (1994) Modifications of human and viral deoxyribonucleic acid by formaldehyde fixation. Lab Invest 71:604–611 Baay MF, Quint WG, Koudstaal J, Hollema H, Duk JM, Burger MP, Stolz E, Herbrink P (1996) Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol 34(3):745–747 Zappacosta R, Colasante A, Viola P, D’Antuono T, Lattanzio G, Capanna S, Gatta DM, Rosini S (2013) Chromogenic in situ hybridization and p16/Ki67 dual staining on formalin-fixed paraffin-embedded cervical specimens: correlation with HPV-DNA test, E6/E7 mRNA test, and potential clinical applications. Biomed Res Int 2013:453606. doi:10.1155/2013/453606 Yavuzer D, Karadayi N, Salepci T, Baloglu H, Bilici A, Sakirahmet D (2011) Role of human papillomavirus in the development of urothelial carcinoma. Med Oncol 28(3):919–923 Panagiotakis GI, Papadogianni D, Chatziioannou MN, Lasithiotaki I, Delakas D, Spandidos DA (2013) Association of human herpes, papilloma and polyoma virus families with bladder cancer. Tumour Biol 34(1):71–79 Knowles MA (1992) Human papillomavirus sequences are not detectable by Southern blotting or general primer-mediated polymerase chain reaction in transitional cell tumours of the bladder. Urol Res 20(4):297–301 De Gaetani C, Ferrari G, Righi E, Bettelli S, Migaldi M, Ferrari P, Trentini GP (1999) Detection of human papillomavirus DNA in urinary bladder carcinoma by in situ hybridization. Clin Pathol 52(2):103–106 Lu QL, Lalani E-N, Abel P (1997) Human papillomavirus 16 and 18 infection is absent in urinary bladder carcinomas. Eur Urol 31(4):428–432